B
BioMarin Pharmaceutical Inc. (BMRN)
NMS – Real vaqt narxi. Valyuta: USD
52.88
+0.30 (0.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
53.06
+0.18 (0.34%)
Bozor oldidan: May 13, 2026, 4:47 AM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
52.88
+0.30 (0.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
53.06
+0.18 (0.34%)
Bozor oldidan: May 13, 2026, 4:47 AM EDT
This stock has a consensus price target of $90.32 based on the ratings of 29 analysts. The high is $126.00 and the low is $55.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 55 | $ 90.32 | $ 126 |
| O’zgarish | 4.60% | 71.78% | 139.63% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-11 | 30.04% | Goldman Sachs | $69 | Reinstates | Buy → Neutral |
| 2026-05-07 | 118.62% | Canaccord Genuity | $104 → $116 | Maintains | Buy |
| 2026-05-05 | 54.54% | Bernstein | $94 → $82 | Maintains | Outperform |
| 2026-05-05 | 124.27% | Morgan Stanley | $120 → $119 | Maintains | Overweight |
| 2026-05-05 | 24.39% | RBC Capital | $66 → $66 | Reiterates | Sector Perform |